Our Story
Dr. Bjørn Helland-Hansen introducing Bulbitech’s technology and explaining the importance of having a suite of multiple neuro-ophthalmic tests available in daily clinical practice.
Current Tests
Visual Field test
Based on eye movement perimetry our 26-point visual field test screens the patient's visual field in 90 seconds per eye. Measuring the saccadic reaction time, an index for detection of glaucomatous visual field defects, our visual field test quantifies the reaction time towards a peripheral target and detects blind spots
Pupil test
Our pupil test, in four sequences of alternating black and white light patters, simultaneously quantifies both direct and consensual pupillary light reflex in order to detect Relative Afferent Pupil Defect (RAPD)
Ptosis test
Ptosis is a drooping or falling of the upper eyelid and can be one of the first signs of stroke, brain tumour, cancer, neurological disorders or damage to the nerves or muscles supporting the eyelid
Saccade test
Performed during the visual field test our saccade test measures the peak velocity of horizontal, vertical and oblique saccades to early detect potential neurological diseases, such as Parkinson's disease, dementia or Huntington's disease
Upcoming Tests
Acuity test
Eye tracking based acuity testing is objective, doesn’t require operational assistance, and takes just 60 seconds
Nystagmus test
Nystagmus is a “wobbling eye” due to an involuntary eye movement. Nystagmus prevalence is estimated to be 24 persons in a 10.000 population. Currently there is no objective quantification of nystagmus
Strabismus test
Eye deviations are manually assessed, and subjectively interpreted. BulbiCAM will quantify the results of horizontal and vertical eye deviations
Cover test
Automated eye deviation tested using eye tracking technology. Patient stimulus allows the measurement of eye positions under single and alternating cover-uncover test
Vergence test
Automated smooth vergence assessment, using virtually 3D stimulus, gives quantified data for near point of convergence and recovery including near pupil reflex
Benefits of our technology
- Early detects neuro-ophthalmic disorders
- Reduces treatment costs
- Reduces patient chair time
- Objectives clinical outcome of neuro-ophthalmic examinations
- Decentralizes access to neuro-ophthalmic testing
- Adds neurological part of the eye examination to your service
- Optimizes profit per neuro-ophthalmic examination
The problems we solve
- Absence of a dedicated neuro-ophthalmic diagnostic device during the eye examination
- Manually or not performing the important neurological part of the eye examination
- Subjective clinical interpretation of neuro-ophthalmic tests results
- Single test units for every examination
- Manually inserting test results
- Inefficient clinical workflow
- Not able to bill the neurological part of the eye examination
Our purpose
Our goal is to provide neuro-ophthalmologists, ophthalmologists and optometrists with a neuro-ophthalmic diagnostic support device for the early detection of neuro-ophthalmic disorders, based on eye tracking technology. Our BulbiCAM offers the user multiple neuro-ophthalmic examinations of which the outcome can be assessed in our BulbiHUB software, making it possible to quickly and objectively add the neurological part of the eye examination to your diagnostic workflow. In addition results can be shared amongst clinicians through our telemedicine functionality, facilitating the patient to undergo the examination at a physical location while the neuro-ophthalmologist is working remotely. Ultimately our BulbiCAM requires the patient to do the work, can be operated by anyone and generates objective clinical results needed to fully assess the patient’s neuro-ophthalmic condition.
Early detection of neuro-ophthalmic disorders with a dedicated diagnostic device that reduces patient chair time
Decentralizing access to neuro-ophthalmic examinations providing remote accessibility to patient's test results for neuro-ophthalmic specialists
Supporting already understaffed eye care professionals to face an increase demand of eye care by providing them a neuro-ophthalmic diagnostic support device in which the patient does the work and can be operated by anyone
Generating objective clinical results, reducing manually performed neuro-ophthalmic examinations
BulbiCAM
One neuro-ocular diagnostic device offering multiple examinations
- 400 FPS eyetracking
- Two screens for independent presentation to each eye
- Accurate timing synchronization
- Calibration free eye tracking test setup
- Individual compensation of refractive errors and head shape
- Patients can be tested standing, sitting or laying
- No table space required
- Expected date of CE-certificate: Q4-2020
More information is coming soon. To stay updated please register your interest and subscribe to our newsletter
Our solution
BulbiHUB software
Software enables users to assess clinical outcome of all eye examination tests conducted with our BulbiCAM. Furthermore it is able to process clinical outcome from eye examinations conducted with third party ophthalmic devices resulting in one unique clinical dashboard overview of clinical test results
Telemedicine
Data can be shared, tele ophthalmology consultations with patients are possible and third-party devices can be integrated, resulting in a clinical workflow that can continue remotely during pandemic outbreaks
AI [Artificial Intelligence]
Algorithms can be developed to detect early stage neuro- ocular dysfunctions and analyze our collected “big data” in order to become the first company that generates AI analysis on eye tracking data
Our company
Our Timeline
2015
Funding from public funds and private investors for technology development
Technical R&D development on eye tracking
Company & software CE-marks based on QMS
Funding from public funds and private investors to complete smaller prototype
2019
Finalist in the DNB Healthcare prize
2020
Bulbitech wins healthcare pitching contest at Oslo Innovation Week
Frozen BulbiCAM prototypes for clinical testing
Our team
Board
ODD HJELMELAND
TOR ULLEBERG
KENT THOMAS HÅGENSTAD RANUM
HARALD FREDRIK ULLTVEIT-MOE
Ophthalmologist
Management team
BÅRD DALHØI
HANS-PETER KURZ
DENNIS HENS
BJØRN A. HELLAND-HANSEN, MD
ATLE MAGNUS ØVREBUST
Clinical Advisory Board
KLAUS A. SJØHAUG
Optometrist/Doctor of Optometry
JOHAN PEL
Associate Professor Neuroscience
HANS VAN DER STEEN
Professor Neuroscience
STIG LARSEN
Professor Controlled Clinical Research Methodology and Statistics
Partners
